Healthy Skepticism Library item: 6776

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Mansfield P, Vitry A.
Re: the promotion of prescription products in Australia
1997 Dec;

Abstract:

Over a year ago MaLAM complained to the Therapeutic Goods Administration about midleading promotion of Coversyl (perindopril) and Adifax (dexfenfluramine) by Servier but has yet to hear back about the resolution of the complaint. MaLAM is also concerned that the findings of the Code of Conduct Subcommittee are not publicly reported.

Keywords:
*analysis/Australia/developed countries/Servier/perindopril/Coversyl/Adifax/dexfenfluramine/ Australian Pharmaceutical Manufacturers Association/ Code of Conduct (Aus)/ regulation of promotion/Medical Lobby for Appropriate Marketing/MaLAM/ regulatory authorities/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION/REGULATION, CODES, GUIDELINES: INDUSTRY SELF-REGULATION